Clinical Trials Directory

Trials / Completed

CompletedNCT01084226

Rye Bread Trial; Antioxidative and Cholesterol Lowering Effects

Dietary Intervention Trial of Alkylresorcinols and Plant Sterols in High-Fibre Rye Bread and Their Effects on Serum Lipids in Normo- and Mildly Hypercholesterolemic Subjects

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
68 (actual)
Sponsor
University of Helsinki · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the antioxidative effects of alkylresorcinols (AR), originating from the rye fiber, on serum LDL particles and the use of AR or it's metabolites as biomarkers for rye fiber intake and the effect of additional plants sterols, incorporated in the rye bread, on serum total and LDL cholesterol concentration.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTRye-2008

Timeline

Start date
2008-02-01
Primary completion
2009-04-01
Completion
2010-02-01
First posted
2010-03-10
Last updated
2010-03-10

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01084226. Inclusion in this directory is not an endorsement.

Rye Bread Trial; Antioxidative and Cholesterol Lowering Effects (NCT01084226) · Clinical Trials Directory